What should be in your roadmap is the advice to get a complete set of EBV testing, including EBNA, EA, and VCA IgM and IgG, along with a PCR test.
If you can provide documented details of the appropriateness of such a testing for ME/CFS patients from an ME/CFS expert, then I can include it. I need to provide reference links in the roadmap to studies, articles or videos which back up every statement made in the roadmap.
As an example of a reference link, this document by Dr Lerner details his testing protocol:
ME/CFS Treatment Resource Guide for Practitioners, see page 4.
Dr Peterson has also provided a similar document:
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management: The Basics and Beyond.
However, in Peterson's case, his document is just too vague regarding the tests used, so I have not been able to make use of it. He does use PCR for herpesviruses, but does not specify which type of PCR, nor the lab he uses, nor the threshold at which he considers a positive result for active infection (in the case of quantitative PCR).
Peterson is also not very clear in this document whether the PCR is for serum, or for CSF (he is one of the few ME/CFS doctors that does test the CSF).
One of the original purposes and motivations for the roadmap was a political one: lots of doctors believe ME/CFS is "all in the mind," and would thus not consider anything like antiviral treatment. What the roadmap shows is published evidence that viral infections may be present in ME/CFS, and good evidence that treatment of these infections can lead to major improvements in ME/CFS.
The idea is that any medic who happens to read the roadmap may reconsider his "all in the mind" views as a result of the evidence in the roadmap. That's why the evidence has to be solid, and based on good published studies wherever possible.
From the patient perspective, it is also irresponsible to fill the roadmap full of speculative unproven ideas, which you seem to be advocating. Many patients can barely afford testing, or some of the expensive treatments which are involved, such as Valcyte or Valtrex. So you don't want to send patients on a wild goose chase, trying out some speculative treatment which has no proven record of benefit.
Yes, if you have good insurance in the US, your insurer may indulge you in expensive speculative treatments; but if you have not got good insurance, or you live in a country with socialized heath care, then it is likely you will have to pay for the treatments yourself, and you would thus probably not want to use you money on unproven treatments.
Anyway, this discussion would be best moved to the
thread about the roadmap.